Literature DB >> 3098850

Changes in gene expression induced by a phorbol diester: expression of IL 2 receptor, T3, and T cell antigen receptor.

D A Shackelford, A V Smith, I S Trowbridge.   

Abstract

Phorbol esters cause an apparent differentiation of human T leukemic cell lines. It was shown previously that TPA induces the expression of the interleukin 2 (IL 2) receptor and the T3 complex on some T cell lines, including CCRF-CEM. We demonstrate that expression of the IL 2 receptor correlated with an induction of the 3.5 and 1.5 kb IL 2 receptor mRNA. In addition, the TPA-induced expression of the T3 polypeptides was found to be accompanied by induction of a putative T cell antigen receptor heterodimer on CEM cells. This was demonstrated by the co-precipitation of the T cell receptor with T3 from digitonin-solubilized cells. The cells expressed high levels of T3 delta- and T cell receptor beta-chain mRNA in the absence of TPA. The effect of TPA was to cause a rapid accumulation of T cell receptor alpha-chain mRNA. This suggested that the alpha-chain gene was rearranged before TPA induction and that expression of the T cell receptor/T3 complex on the cell surface was regulated by the level of alpha-chain expression. It was also shown that cloned sublines of CEM cells which expressed different T cell antigen phenotypes differed in their response to TPA.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3098850

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Functionally distinct isoforms of the CRE-BP DNA-binding protein mediate activity of a T-cell-specific enhancer.

Authors:  K Georgopoulos; B A Morgan; D D Moore
Journal:  Mol Cell Biol       Date:  1992-02       Impact factor: 4.272

2.  Increased numbers of T lymphocytes with gamma delta-positive antigen receptors in a subgroup of individuals with pulmonary sarcoidosis.

Authors:  B Balbi; D R Moller; M Kirby; K J Holroyd; R G Crystal
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

3.  At least two non-antigen-binding molecules are required for signal transduction by the T-cell antigen receptor.

Authors:  M A Goldsmith; P F Dazin; A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

4.  Transcriptional and post-transcriptional regulation of TcR, CD4 and CD8 gene expression during activation of normal human T lymphocytes.

Authors:  F Paillard; G Sterkers; C Vaquero
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

5.  Comparison of T cell receptor alpha, beta, and gamma gene rearrangement and expression in T cell acute lymphoblastic leukemia.

Authors:  J Hara; S H Benedict; E Champagne; T W Mak; M Minden; E W Gelfand
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

6.  Discordant expression of CD3 and T-cell receptor beta-chain antigens in T-lineage lymphomas.

Authors:  L J Picker; M B Brenner; L M Weiss; S D Smith; R A Warnke
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

7.  A T cell-specific enhancer is located in a DNase I-hypersensitive area at the 3' end of the CD3-delta gene.

Authors:  K Georgopoulos; P van den Elsen; E Bier; A Maxam; C Terhorst
Journal:  EMBO J       Date:  1988-08       Impact factor: 11.598

8.  A novel, inducible and T cell-specific enhancer located at the 3' end of the T cell receptor alpha locus.

Authors:  A Winoto; D Baltimore
Journal:  EMBO J       Date:  1989-03       Impact factor: 11.598

9.  Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene.

Authors:  I C Ho; P Vorhees; N Marin; B K Oakley; S F Tsai; S H Orkin; J M Leiden
Journal:  EMBO J       Date:  1991-05       Impact factor: 11.598

10.  Cloning of murine TCF-1, a T cell-specific transcription factor interacting with functional motifs in the CD3-epsilon and T cell receptor alpha enhancers.

Authors:  M Oosterwegel; M van de Wetering; D Dooijes; L Klomp; A Winoto; K Georgopoulos; F Meijlink; H Clevers
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.